As of Nov 27
| +0.06 / +0.14%|
The 29 analysts offering 12-month price forecasts for Sanofi have a median target of 50.97, with a high estimate of 61.76 and a low estimate of 40.01. The median estimate represents a +15.02% increase from the last price of 44.31.
The current consensus among 31 polled investment analysts is to Hold stock in Sanofi. This rating has held steady since November, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.